Back to search
FDAFDA · Food and drugs·Recall number D-0571-2016

Lindane Lotion, USP 1%, For External use Only, Rx Only, 2 fl oz (60 mL) bottle, MGP, NDC 60432-833-60

Published January 27, 2016 · Recall initiated: December 15, 2015

Summary

FDA records drug Class III recall D-0571-2016, published January 27, 2016 and initiated December 15, 2015. Recalling firm: Morton Grove Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 39,187 bottles; Lot: Lot #: UP1103, Exp 04/2016; UQ1001, Exp 04/2017. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Super-Potent Drug: Out of Specification Assay test results were reported for stability samples.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Morton Grove Pharmaceuticals, Inc.
Distributor
Nationwide and Puerto Rico
Lot
Lot #: UP1103, Exp 04/2016; UQ1001, Exp 04/2017
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lindane Lotion, USP 1%, For External use Only, Rx Only, 2 fl oz (60 mL) bottle, MGP, NDC 60432-833-60 recalled?

Yes. FDA published recall D-0571-2016 on January 27, 2016. Reported hazard: Super-Potent Drug: Out of Specification Assay test results were reported for stability samples.

What should I do if I have this product?

Voluntary: Firm initiated · Letter